In this episode of Good Medicine, Dr. David Bearss sits down with Matt Bresnahan, a partner at Wilson Sonsini Goodrich & Rosati, to demystify the world of patents in biotech and life sciences. Together, they explore what makes an innovation patent-eligible, how the 21-year patent timeline works, and how the U.S. patent system incentivizes solving unmet medical needs—ultimately helping patients access breakthrough drugs at lower costs.
Whether you're a biotech founder, researcher, or just curious about how innovation becomes accessible medicine, this episode offers clear, practical insight into one of the most important—but misunderstood—parts of the life sciences ecosystem.🔗 New episodes every Tuesday. Subscribe to stay in the loop on healthcare, innovation, and policy.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: https://www.instagram.com/good.medicine.podcast/ X: https://x.com/GoodMedicinePod TikTok: https://www.tiktok.com/@good.medicine.podcast LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/